tiprankstipranks
RemeGen Co. Ltd. Class H (HK:9995)
:9995
Hong Kong Market

RemeGen Co. Ltd. Class H (9995) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

9995 Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
RemeGen
Co. Ltd. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

9995 Stock 12 Month Forecast

Average Price Target

HK$129.44
▲(22.11% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for RemeGen Co. Ltd. Class H in the last 3 months. The average price target is HK$129.44 with a high forecast of HK$136.90 and a low forecast of HK$114.00. The average price target represents a 22.11% change from the last price of HK$106.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"HK$16","137":"HK$137","46.25":"HK$46.3","76.5":"HK$76.5","106.75":"HK$106.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":136.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$136.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":129.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$129.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$114.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,46.25,76.5,106.75,137],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.4,112.43846153846154,114.47692307692309,116.51538461538462,118.55384615384617,120.5923076923077,122.63076923076923,124.66923076923078,126.70769230769231,128.74615384615385,130.7846153846154,132.82307692307694,134.86153846153846,{"y":136.9,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.4,111.86461538461539,113.32923076923078,114.79384615384616,116.25846153846155,117.72307692307693,119.18769230769232,120.65230769230769,122.11692307692307,123.58153846153846,125.04615384615384,126.51076923076923,127.97538461538461,{"y":129.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.4,110.67692307692309,110.95384615384616,111.23076923076924,111.50769230769231,111.78461538461539,112.06153846153846,112.33846153846154,112.61538461538461,112.8923076923077,113.16923076923077,113.44615384615385,113.72307692307692,{"y":114,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.15,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.65,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.3,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":117.2,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":90,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":88.4,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":72,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":80.35,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":76.2,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$136.90Average Price TargetHK$129.44Lowest Price TargetHK$114.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:9995
Unknown Analyst
CICC
Not Ranked
CICC
HK$133.71
Buy
26.14%
Upside
Reiterated
04/02/26
CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
J.P. Morgan Analyst forecast on HK:9995
J.P. Morgan
J.P. Morgan
HK$129
Buy
21.70%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from J.P. Morgan
BOCOM International Holdings Company Analyst forecast on HK:9995
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
HK$136
Buy
28.30%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from BOCOM International Holdings Company
Bank of China Analyst forecast on HK:9995
Unknown Analyst
Bank of China
Not Ranked
Bank of China
HK$127
Buy
19.81%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Bank of China
CLSA
HK$103HK$136.9
Buy
29.15%
Upside
Reiterated
03/27/26
We lift our target price from HK$103.00 to HK$136.90. Maintain Outperform.
Zhongtai Securities Analyst forecast on HK:9995
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
HK$114
Buy
7.55%
Upside
Upgraded
01/20/26
RemeGen Co. Ltd. Class H (9995) was upgraded to a Buy Rating at Zhongtai Securities
UBS
HK$63.8
Hold
-39.81%
Downside
Reiterated
12/09/25
RemeGen Co. Ltd. Class H (9995) Gets a Hold from UBS
Citic Securities Analyst forecast on HK:9995
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$97
Buy
-8.49%
Downside
Reiterated
12/01/25
Citic Securities Remains a Buy on RemeGen Co. Ltd. Class H (9995)
CCB Intl. Analyst forecast on HK:9995
Unknown Analyst
CCB Intl.
Not Ranked
CCB Intl.
HK$120
Buy
13.21%
Upside
Reiterated
11/14/25
Morgan Stanley Analyst forecast on HK:9995
Morgan Stanley
Morgan Stanley
HK$89
Hold
-16.04%
Downside
Reiterated
10/30/25
Huatai Securities Analyst forecast on HK:9995
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$139.96
Buy
32.04%
Upside
Reiterated
10/19/25
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Huatai Securities
Macquarie Analyst forecast on HK:9995
Macquarie
Macquarie
HK$51HK$64
Sell
-39.62%
Downside
Reiterated
09/08/25
Macquarie Reaffirms Their Sell Rating on RemeGen Co. Ltd. Class H (9995)
Nomura
HK$16.37HK$47.6
Hold
-55.09%
Downside
Reiterated
05/23/25
Remegen Co Ltd (9995:HK) PT Raised to HK$47.60 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang raised the price target on Remegen Co Ltd (9995:HK) to HK$47.60 (from HK$16.37) while maintaining a Neutral rating.
SWS Res Analyst forecast on HK:9995
Unknown Analyst
SWS Res
Not Ranked
SWS Res
HK$50
Buy
-52.83%
Downside
Reiterated
04/29/25
Guotai Haitong Analyst forecast on HK:9995
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$59.44
Buy
-43.92%
Downside
Reiterated
04/27/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:9995
Unknown Analyst
CICC
Not Ranked
CICC
HK$133.71
Buy
26.14%
Upside
Reiterated
04/02/26
CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
J.P. Morgan Analyst forecast on HK:9995
J.P. Morgan
J.P. Morgan
HK$129
Buy
21.70%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from J.P. Morgan
BOCOM International Holdings Company Analyst forecast on HK:9995
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
HK$136
Buy
28.30%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from BOCOM International Holdings Company
Bank of China Analyst forecast on HK:9995
Unknown Analyst
Bank of China
Not Ranked
Bank of China
HK$127
Buy
19.81%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Bank of China
CLSA
HK$103HK$136.9
Buy
29.15%
Upside
Reiterated
03/27/26
We lift our target price from HK$103.00 to HK$136.90. Maintain Outperform.
Zhongtai Securities Analyst forecast on HK:9995
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
HK$114
Buy
7.55%
Upside
Upgraded
01/20/26
RemeGen Co. Ltd. Class H (9995) was upgraded to a Buy Rating at Zhongtai Securities
UBS
HK$63.8
Hold
-39.81%
Downside
Reiterated
12/09/25
RemeGen Co. Ltd. Class H (9995) Gets a Hold from UBS
Citic Securities Analyst forecast on HK:9995
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$97
Buy
-8.49%
Downside
Reiterated
12/01/25
Citic Securities Remains a Buy on RemeGen Co. Ltd. Class H (9995)
CCB Intl. Analyst forecast on HK:9995
Unknown Analyst
CCB Intl.
Not Ranked
CCB Intl.
HK$120
Buy
13.21%
Upside
Reiterated
11/14/25
Morgan Stanley Analyst forecast on HK:9995
Morgan Stanley
Morgan Stanley
HK$89
Hold
-16.04%
Downside
Reiterated
10/30/25
Huatai Securities Analyst forecast on HK:9995
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$139.96
Buy
32.04%
Upside
Reiterated
10/19/25
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Huatai Securities
Macquarie Analyst forecast on HK:9995
Macquarie
Macquarie
HK$51HK$64
Sell
-39.62%
Downside
Reiterated
09/08/25
Macquarie Reaffirms Their Sell Rating on RemeGen Co. Ltd. Class H (9995)
Nomura
HK$16.37HK$47.6
Hold
-55.09%
Downside
Reiterated
05/23/25
Remegen Co Ltd (9995:HK) PT Raised to HK$47.60 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang raised the price target on Remegen Co Ltd (9995:HK) to HK$47.60 (from HK$16.37) while maintaining a Neutral rating.
SWS Res Analyst forecast on HK:9995
Unknown Analyst
SWS Res
Not Ranked
SWS Res
HK$50
Buy
-52.83%
Downside
Reiterated
04/29/25
Guotai Haitong Analyst forecast on HK:9995
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$59.44
Buy
-43.92%
Downside
Reiterated
04/27/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering RemeGen Co. Ltd. Class H

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+18.00%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +18.00% per trade.
1 Year
Tony RenMacquarie
Success Rate
1/1 ratings generated profit
100%
Average Return
+8.20%
reiterated a sell rating 7 months ago
Copying Tony Ren's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.20% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+8.20%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +8.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

9995 Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
1
1
1
Buy
4
4
3
7
10
Hold
27
27
31
23
21
Sell
12
10
5
0
0
Strong Sell
0
0
0
0
0
total
43
41
40
31
32
In the current month, 9995 has received 11 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. 9995 average Analyst price target in the past 3 months is 129.44.
Each month's total comprises the sum of three months' worth of ratings.

9995 Financial Forecast

9995 Earnings Forecast

The previous quarter’s earnings for 9995 were HK$2.47.
The previous quarter’s earnings for 9995 were HK$2.47.

9995 Sales Forecast

The previous quarter’s earnings for 9995 were HK$1.68B.
The previous quarter’s earnings for 9995 were HK$1.68B.

9995 Stock Forecast FAQ

What is HK:9995’s average 12-month price target, according to analysts?
Based on analyst ratings, RemeGen Co. Ltd. Class H’s 12-month average price target is 129.44.
    What is HK:9995’s upside potential, based on the analysts’ average price target?
    RemeGen Co. Ltd. Class H has 22.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RemeGen Co. Ltd. Class H a Buy, Sell or Hold?
          RemeGen Co. Ltd. Class H has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is RemeGen Co. Ltd. Class H’s share price target?
            The average share price target for RemeGen Co. Ltd. Class H is 129.44. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$136.90 ,and the lowest forecast is HK$114.00. The average share price target represents 22.11% Increase from the current price of HK$106.
              What do analysts say about RemeGen Co. Ltd. Class H?
              RemeGen Co. Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of RemeGen Co. Ltd. Class H?
                To buy shares of HK:9995, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.